How much funding has Alltrna raised?

Alltrna has raised $159.0M in total funding, most recently a Series B round.

Who are Alltrna's investors?

Alltrna's investors include Flagship Pioneering.

Where is Alltrna headquartered?

Alltrna is headquartered in Cambridge, Massachusetts, United States.

Alltrna

The world's first tRNA platform company.

Cambridge, United States · Founded 2018 · $159.0M raised

Biotech

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: alltrna.com
Total Funding: $159.0M
Last Round: $109.0M Series BAug 2023
Rounds: 2

About

Alltrna is a clinical-stage biotech company founded in 2018 by Flagship Pioneering to develop the world's first tRNA medicine platform. By systematically mapping tRNA biology, Alltrna engineers transfer RNA therapeutics that can correct shared genetic mutations and restore disrupted protein production across thousands of diseases. The company is headquartered in Cambridge, Massachusetts, and has advanced its lead program AP003 into first-in-human clinical trials.

Summary

Alltrna is a Biotech company based in Cambridge, United States, founded in 2018. It has raised $159.0M in total across 2 rounds, most recently a $109.0M Series B round in Aug 2023. Investors include Flagship Pioneering.

LinkedIn X (Twitter)